Current clinical practice guidelines recommend a target Hb of 7–9 g/dL, and for TBI patients who show signs of cerebral ischemia, a target Hb level exceeding 9 g/dL is recommended [92,94]. The gene discussed is GSTM1; the disease is brain ischemia.